6 completed, 2 terminated, 2 unknown, 2 withdrawn. 5 Phase 4, 4 Not applicable, 2 Phase 2, 2 Phase 3, 1 Phase 1.
Follow Dialysis Solutions: new trials by email Literature Review of Dialysis Solutions trials Research Report on Dialysis Solutions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients amino acid (15) peritoneal dialysis solution - End-stage Renal Disease (ESRD), Peritoneal Dialysis (PD) | Phase 4 | Enrolling by invitation | Shanghai 10th People's Hospital | 50 | 2026-05-01 | 2026-04-28 |
| Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition. amino acid (15) peritoneal dialysis solution, glucose peritoneal dialysis solution - End Stage Renal Disease (ESRD) | Phase 4 | Recruiting | Chengdu Qingshan Likang Pharmaceutical Co., Ltd | 400 | 2024-08-09 | 2024-12-30 |
| Regional Citrate Anticoagulation for RRT During V-V ECMO Unfractionated heparin + RCA first, Unfractionated heparin first - ARDS, Human, Acute Kidney Injury | Not applicable | Completed | University of Milano Bicocca | 18 | 2021-11-14 | 2026-05-07 |
| Efficacy and Safety of a Citrate-based Anticoagulation With Calcium-free Phosphate-containing Fluid in Renal Replacement Therapy Biphozyl (dialysate and replacement), Prismocal B22 (dialysate) + phoxilium (replacement) - Critical Care | Phase 4 | Unknown | Assistance Publique Hopitaux De Marseille | 100 | 2020-05-02 | 2020-01-02 |
| Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine Icodextrin, xylitol and carnitine solution for peritoneal dialysis, EXTRANEAL 7.5G/100Ml Peritoneal Dialysis Solution - End Stage Renal Disease (ESRD) | Phase 2 | Withdrawn | Iperboreal Pharma Srl | 2019-10-02 | 2024-10-01 | |
| Direct Peritoneal Resuscitation in Gastroschisis SoC Staged Silo Closure, Peritoneal Dialysis Solution/Dextrose 1.5% - Gastroschisis | Phase 1 | Terminated | University of Arkansas | 3 | 2018-02-01 | 2021-12-20 |
| A Controlled and Multi-Center Study of 2500ml Huaren Peritoneal Dialysate 2500ml Huaren peritoneal dialysate, 2000ml peritoneal dialysate - Disorders Associated With Peritoneal Dialysis | Not applicable | Unknown | Sun Yat-sen University | 300 | 2015-01-01 | 2015-03-19 |
| Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation Dialysis Solutions - Renal Insufficiency, Chronic, Inflammation | Phase 2 / Phase 3 | Completed | A.O.U. Città della Salute e della Scienza | 45 | 2014-10-30 | 2018-07-09 |
| Effects of Simple Sodium Alignment on Clinical Outcomes Dialysate and serum sodium concentration aligned - Complication of Hemodialysis | Completed | Renal Research Institute | 148 | 2011-05-01 | 2016-02-24 | |
| Effect of Different Dialysis Dosage on Prognosis in Maintenance Peritoneal Dialysis Patients 6 L dialysate, 8 L dialysate - End-stage Renal Disease | Phase 4 | Completed | Shanghai Jiao Tong University School of Medicine | 200 | 2009-03-01 | 2016-10-13 |
| Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD Solution for Peritoneal Dialysis - Chronic Kidney Failure | Phase 3 | Completed | Fresenius Medical Care Deutschland GmbH | 140 | 2008-10-01 | 2015-02-27 |
| Potassium in Haemodialysis Fluids and Haemodynamics Changing potassium concentration in dialysis fluids - Haemodialysis | Not applicable | Completed | Ospedale Regionale di Locarno | 24 | 2007-09-01 | 2010-10-20 |
| Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients Extraneal (7.5% icodextrin) Peritoneal Dialysis Solution - Peritoneal Dialysis, Hypertriglyceridemia | Phase 4 | Withdrawn | Vantive Health LLC | 2006-11-01 | 2025-03-03 | |
| Changes in Cardiovascular Hemodynamics During Peritoneal Dialysis Icodextrin (dialysate), Physioneal (dialysate) 1.36% and 2.27% - Peritoneal Dialysis | Not applicable | Terminated | University of Aarhus | 15 | 2006-01-01 | 2008-12-08 |
Kidney Failure, Chronic (5) · Acute Kidney Injury (1) · Diabetes Insipidus (1) · Gastroschisis (1) · Hypertension (1) · Hypertriglyceridemia (1) · Hypotension (1) · Inflammation (1) · Malnutrition (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Respiratory Distress Syndrome (1)
A.O.U. Città della Salute e della Scienza (1) · Assistance Publique Hopitaux De Marseille (1) · Chengdu Qingshan Likang Pharmaceutical Co., Ltd (1) · Fresenius Medical Care Deutschland GmbH (1) · Iperboreal Pharma Srl (1) · Ospedale Regionale di Locarno (1) · Renal Research Institute (1) · Shanghai 10th People's Hospital (1) · Shanghai Jiao Tong University School of Medicine (1) · Sun Yat-sen University (1) · University of Aarhus (1) · University of Arkansas (1) · University of Milano Bicocca (1) · Vantive Health LLC (1)
China (4) · United States (3) · Denmark (2) · Italy (2) · France (1) · Germany (1) · Sweden (1) · Switzerland (1) · United Kingdom (1)
Bengt Rippe, Prof (1) · Luca Gabutti, MD (1) · Mario Bonomini, MD (1) · Patrick C Bonasso, MD (1) · Per Ivarsen (1) · Peter Kotanko, MD (1) · Samuel Smith, MD (1) · Simon Davies, Prof (1) · Vedat Schwenger, Dr (1) · Zongpei Jiang, M.D. & Ph.D. (1)
PMID 21470404, PMID 24727536, PMID 25128022, PMID 25881975, PMID 29609536, PMID 31045918, PMID 33095849, PMID 42088147